<DOC>
	<DOCNO>NCT01792518</DOCNO>
	<brief_summary>Evaluate linagliptin term glycemic control define HbA1c 24 week treatment term renal efficacy define change albuminuria ( UACR ) 24 week treatment .</brief_summary>
	<brief_title>MARLINA - T2D : Efficacy , Safety &amp; Modification Albuminuria Type 2 Diabetes Subjects With Renal Disease With LINAgliptin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Inclusion criterion : Diagnosis type 2 diabetes mellitus Glycosylated Hemoglobin ( HbA1c ) 6.5 10 % ( inclusive ) Current therapy ACEi ARB stable dose 10 week Urinary albumintocreatinine ratio ( UACR ) : 303000 mg/g creatinine document previous 12 month detect Screening . Estimated Glomerular Filtration Rate ( eGFR ) great 30 ml/min . Age 18 80 year . Exclusion criterion : Dual triple blockade Renin Angiotensin System ( RAS ) Uncontrolled hyperglycaemia Mean arterial blood pressure &gt; 110 mmHg Known hypersensitivity allergy investigational product , excipients ( include match placebo ) . Treatment glitazone within 6 month prior inform consent . Treatment DiPeptidylPeptidase 4 ( DPP4 ) inhibitor , Glucagon Like Peptide1 ( GLP1 ) agonist , Sodium/Glucose coTransporter 2 ( SGLT2 ) inhibitor , dopamineagonist , bileacid sequestrant short acting ( prandial ) insulin premixed insulin within 10 week prior inform consent . Treatment antiobesity drug 10 week prior inform consent . Alcohol drug abuse within 3 month prior inform consent would interfere trial participation ongoing condition lead decrease compliance study procedure study drug intake opinion investigator . Current treatment systemic steroid ( glucocorticoid ) time informed consent change dosage thyroid hormone within 6 week prior inform consent . Participation another trial investigational drug within 2 month prior inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>